Sulopenem-Etzadroxil/Probenecid

DRUG3 trials

Sponsors

Iterum Therapeutics, International Limited

Conditions

Complicated Urinary Tract InfectionsIntra Abdominal InfectionsUncomplicated Urinary Tract Infections

Phase 3

Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women

CompletedNCT03354598

Iterum Therapeutics, International LimitedUncomplicated Urinary Tract Infections

Start: 2018-08-01End: 2020-01-20Updated: 2021-01-12

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

CompletedNCT03358576

Iterum Therapeutics, International LimitedIntra Abdominal Infections

Start: 2018-09-18End: 2019-10-02Updated: 2020-12-01

Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults

CompletedNCT03357614

Iterum Therapeutics, International LimitedComplicated Urinary Tract Infections

Start: 2018-09-18End: 2019-12-14Updated: 2020-12-29

Related Papers

Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial

Clinical Infectious Diseases2022-09-0735 citations

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial

Clinical Infectious Diseases2022-09-0733 citations